Maxcyte reported a gross margin of 76.96% and a net margin of -122.05% for the quarter ended Jun 2026. These financial ratios cover 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||
| Gross Margin | 90.69% | 87.92% | 90.83% | 88.34% | 87.14% | 87.55% | 88.34% | 84.78% | 90.09% | 89.96% | 87.63% | 85.73% | 76.38% | 73.76% | 85.59% | 82.14% | 76.63% | 77.95% | 83.74% | 76.96% | |||||
| EBT Margin | -26.44% | -48.01% | -35.10% | -85.97% | -60.45% | -38.71% | -126.89% | -116.24% | -140.57% | -33.69% | -83.99% | -89.89% | -141.56% | -121.90% | -98.76% | -145.26% | -181.81% | -131.45% | -49.22% | -122.05% | |||||
| EBIT Margin | -24.09% | -48.81% | -35.89% | -90.96% | -72.46% | -54.34% | -153.66% | -144.56% | -174.31% | -51.68% | -108.23% | -114.76% | -172.13% | -148.41% | -118.33% | -167.24% | -207.19% | -153.78% | -64.09% | -140.72% | |||||
| EBITDA Margin | -24.09% | -48.81% | -35.89% | -90.96% | -72.46% | -54.34% | -153.66% | -144.56% | -174.31% | -51.68% | -108.23% | -104.39% | -159.08% | -136.25% | -107.88% | -154.44% | -191.71% | -139.33% | -53.41% | -127.51% | |||||
| Operating Margin | -24.09% | -48.81% | -35.89% | -90.96% | -72.46% | -54.34% | -153.66% | -144.56% | -174.31% | -51.68% | -108.23% | -114.76% | -172.13% | -148.41% | -118.33% | -167.24% | -207.19% | -153.78% | -64.09% | -140.72% | |||||
| Net Margin | -26.44% | -48.01% | -35.10% | -85.97% | -60.45% | -38.71% | -126.89% | -116.24% | -140.57% | -33.69% | -83.99% | -89.89% | -141.56% | -121.90% | -98.76% | -145.26% | -181.81% | -131.45% | -49.22% | -122.05% | |||||
| FCF Margin | -17.09% | -20.51% | -83.66% | -61.27% | -88.31% | -66.66% | -68.59% | -117.35% | -111.92% | 0.42% | -100.23% | -49.17% | -58.76% | -91.66% | -144.99% | -122.68% | -113.60% | -40.00% | -85.96% | -42.43% | |||||
| Efficiency | |||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 4.16M | 4.68M | 5.89M | 7.15M | 7.82M | 8.25M | 9.42M | 10.64M | 11.78M | 12.38M | 12.09M | 11.56M | 10.78M | 9.65M | 8.59M | 8.10M | 7.77M | 7.58M | 7.59M | 7.71M | |||||
| Assets AverageAssets Avg. | 185.42M | 280.90M | 287.54M | 290.37M | 288.09M | 286.53M | 284.10M | 276.37M | 268.97M | 267.50M | 263.10M | 254.71M | 250.05M | 244.04M | 234.72M | 224.86M | 216.61M | 207.99M | 198.49M | 189.57M | |||||
| Invested CapitalInvested Cap. | |||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.17 | 0.12 | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 | 0.14 | 0.15 | 0.17 | 0.18 | 0.18 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | |||||
| Leverage & Solvency | |||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -8.45 | -66.48 | -613.70 | ||||||||||||||||||||||
| Debt Ratio | |||||||||||||||||||||||||
| Times Interest Earned | -8.45 | -66.48 | -613.70 | ||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||
| Price to EarningsP/E | -457.51 | -211.57 | -174.45 | -58.21 | -102.95 | -116.25 | -46.81 | -45.03 | -28.72 | -92.58 | -45.92 | -43.83 | -35.44 | -41.50 | -28.29 | -18.80 | -13.57 | -17.25 | -15.84 | -14.71 | |||||
| Price to SalesP/S | 120.95 | 101.58 | 61.24 | 50.05 | 62.24 | 45.00 | 59.40 | 52.35 | 40.36 | 31.19 | 38.57 | 39.40 | 50.17 | 50.59 | 27.93 | 27.32 | 24.67 | 22.67 | 7.80 | 17.95 | |||||
| Price to BookP/B | 4.64 | 3.92 | 2.71 | 1.87 | 2.60 | 2.20 | 2.06 | 1.96 | 1.38 | 2.10 | 1.93 | 1.86 | 1.92 | 2.13 | 1.46 | 1.22 | 0.93 | 0.97 | 0.45 | 0.82 | |||||
| Enterprise Value | 970.41M | 776.21M | 463.28M | 239.97M | 429.49M | 331.75M | 284.73M | 257.28M | 132.83M | 320.33M | 279.94M | 253.58M | 255.79M | 285.28M | 151.97M | 105.81M | 62.77M | 62.48M | -31.60M | 24.85M | |||||
| EV to EBIT | -397.24 | -156.65 | -111.39 | -27.46 | -55.69 | -49.14 | -21.61 | -19.68 | -9.52 | -39.57 | -22.81 | -21.19 | -18.20 | -22.11 | -12.36 | -7.44 | -4.44 | -5.57 | 5.11 | -2.43 | |||||
| EV to EBITDA | -397.24 | -156.65 | -111.39 | -27.46 | -55.69 | -49.14 | -21.61 | -19.68 | -9.52 | -39.57 | -22.81 | -23.29 | -19.70 | -24.09 | -13.56 | -8.05 | -4.79 | -6.14 | 6.13 | -2.68 | |||||
| Market Capitalization | 1,226.30M | 1,031.26M | 709.55M | 480.86M | 662.38M | 559.09M | 509.38M | 473.39M | 323.07M | 488.62M | 437.46M | 410.91M | 409.62M | 439.76M | 290.24M | 232.37M | 168.50M | 165.52M | 75.25M | 130.54M | |||||
| Price to FCFP/FCF | -707.90 | -495.22 | -73.20 | -81.69 | -70.47 | -67.52 | -86.60 | -44.61 | -36.07 | 0.01M | -38.48 | -80.13 | -85.39 | -55.19 | -19.27 | -22.27 | -21.72 | -56.69 | -9.07 | -42.32 | |||||
| EV to FCF | -560.19 | -372.75 | -47.79 | -40.76 | -45.70 | -40.06 | -48.41 | -24.24 | -14.83 | 0.00M | -24.63 | -49.45 | -53.32 | -35.80 | -10.09 | -10.14 | -8.09 | -21.40 | 3.81 | -8.06 | |||||
| EV to CFO | -0.00M | -808.34 | -125.41 | 261.23 | -72.54 | -54.51 | -65.85 | -25.46 | -16.12 | 326.54 | -26.50 | -52.46 | -58.25 | -36.48 | -10.55 | -10.74 | -8.42 | -23.24 | 3.87 | -5.33 | |||||
| Return Ratios | |||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -24.09% | -48.81% | -35.89% | -90.96% | -72.46% | -54.34% | -153.66% | -144.56% | -174.31% | -51.68% | -108.23% | -114.76% | -172.13% | -148.41% | -118.33% | -167.24% | -207.19% | -153.78% | -64.09% | -140.72% | |||||
| Return on Capital Employed [ROCE]ROCE | -9.03% | -6.86% | -5.87% | -7.45% | -9.42% | -10.09% | -13.60% | -15.47% | -18.61% | -19.35% | -18.99% | -19.09% | -19.96% | -22.43% | -23.07% | -25.07% | -26.72% | -26.79% | -24.32% | -23.26% | |||||
| Return on Assets [ROA]ROA | -9.09% | -6.79% | -5.58% | -6.85% | -8.20% | -8.23% | -10.70% | -11.81% | -13.93% | -14.18% | -13.90% | -13.91% | -14.29% | -16.82% | -17.80% | -19.91% | -21.07% | -21.46% | -19.71% | -18.80% |